We are live on ! Find out more
LG

LaFleur & Godfrey Portfolio holdings

AUM $842M Turnover 10.46%
1-Year Est. Return 24.12%
This Fund
S&P 500
This Quarter Est. Return
+3.18%
1 Year Est. Return
+24.12%
3 Year Est. Return
+85.19%
5 Year Est. Return
+109.34%
10 Year Est. Return
+386.09%
AUM
$399M
AUM Growth
-$8.38M
Cap. Flow
-$16.9M
Cap. Flow %
-4.23%
Top 10 Hldgs %
42.3%
Holding
77
New
3
Increased
23
Reduced
30
Closed
15
Avg Time Held
3.7 years
Top 10 Avg Time Held
2.6 years
Top 20 Avg Time Held
2.6 years

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$5.19M
2
APA icon
APA Corp
APA
+$5.11M
3
T icon
AT&T
T
+$3.24M
4
JPM icon
JPMorgan Chase
JPM
+$3.04M
5
GILD icon
Gilead Sciences
GILD
+$2.88M

Sector Composition

Rank Sector Weight
1 Healthcare 25.36%
2 Technology 20.87%
3 Industrials 16.16%
4 Financials 8.78%
5 Materials 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
INTC icon
1
Intel
INTC
$475B
$23.9M 6.01%
459,829
-7,375
-2% -$350K
2013 Q2
19 quarters
RTN
2
DELISTED
Raytheon Company
RTN
$21.5M 5.4%
99,731
-4,855
-5% -$1M
2013 Q2
19 quarters
AAPL icon
3
Apple
AAPL
$5.01T
$18.7M 4.68%
444,660
-241,904
-35% -$10.4M
2013 Q2
19 quarters
ECL icon
4
Ecolab
ECL
$81B
$17.3M 4.34%
126,179
-410
-0.3% -$55.1K
2013 Q2
19 quarters
JPM icon
5
JPMorgan Chase
JPM
$902B
$17.1M 4.29%
155,486
+26,820
+21% +$3.04M
2013 Q2
19 quarters
COP icon
6
ConocoPhillips
COP
$176B
$16.1M 4.04%
271,693
-5,790
-2% -$327K
2013 Q2
19 quarters
SYK icon
7
Stryker
SYK
$113B
$15M 3.77%
93,516
-2,038
-2% -$328K
2013 Q2
19 quarters
VAR
8
DELISTED
Varian Medical Systems, Inc.
VAR
$14.5M 3.65%
118,544
-7,305
-6% -$871K
2013 Q2
19 quarters
CSCO icon
9
Cisco
CSCO
$423B
$12.5M 3.14%
291,589
-1,087
-0.4% -$46.1K
2013 Q2
19 quarters
CPRT icon
10
Copart
CPRT
$25.8B
$11.9M 2.99%
937,560
-32,000
-3% -$370K
2013 Q2
19 quarters
MRK icon
11
Merck
MRK
$360B
$11.9M 2.98%
228,763
-12,654
-5% -$683K
2015 Q3
10 quarters
BA icon
12
Boeing
BA
$150B
$11.2M 2.81%
34,221
-2,686
-7% -$907K
2016 Q1
8 quarters
ABBV icon
13
AbbVie
ABBV
$504B
$10.2M 2.57%
108,111
+702
+0.7% +$77.1K
2013 Q2
19 quarters
PAYX icon
14
Paychex
PAYX
$39.7B
$10.2M 2.57%
166,071
-997
-0.6% -$65.9K
2013 Q2
19 quarters
APA icon
15
APA Corp
APA
$17.2B
$10.1M 2.54%
263,503
+126,982
+93% +$5.11M
2013 Q2
19 quarters
JNJ icon
16
Johnson & Johnson
JNJ
$616B
$9.9M 2.49%
77,616
-312
-0.4% -$42.2K
2013 Q2
19 quarters
VMC icon
17
Vulcan Materials
VMC
$33.4B
$9.9M 2.48%
86,545
+75
+0.1% +$9.45K
2016 Q4
5 quarters
NTNX icon
18
Nutanix
NTNX
$18.1B
$9.22M 2.31%
187,690
+5,980
+3% +$237K
2017 Q2
3 quarters
HOLX icon
19
DELISTED
Hologic
HOLX
$8.3M 2.08%
222,241
+8,425
+4% +$340K
2013 Q2
19 quarters
TFC icon
20
Truist Financial
TFC
$57.5B
$8.05M 2.02%
154,739
+12,630
+9% +$680K
2015 Q3
10 quarters
GNTX icon
21
Gentex
GNTX
$4.43B
$7.71M 1.93%
334,968
-3,092
-0.9% -$70.4K
2013 Q2
19 quarters
MSFT icon
22
Microsoft
MSFT
$3.93T
$7.71M 1.93%
84,481
-2,896
-3% -$265K
2013 Q2
19 quarters
GILD icon
23
Gilead Sciences
GILD
$194B
$7.53M 1.89%
99,862
+36,230
+57% +$2.88M
2017 Q4
1 quarter
WWD icon
24
Woodward
WWD
$19.4B
$6.98M 1.75%
97,339
+3,285
+3% +$247K
2013 Q2
19 quarters
LKQ icon
25
LKQ Corp
LKQ
$5.62B
$6.96M 1.75%
183,395
-1,420
-0.8% -$57.6K
2013 Q2
19 quarters

Similar funds

LaFleur & Godfrey's Q1 2018 Portfolio in Review

As of Q1 2018, LaFleur & Godfrey held 77 positions worth $399M, down 2.1% from $407M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

LaFleur & Godfrey withdrew a net $16.9M in Q1 2018, closing 15 positions and reducing 30 holdings. Its most notable exit was Keurig Dr Pepper, an estimated $5.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

Against the trend, LaFleur & Godfrey opened a new position in Thermo Fisher Scientific worth $5.1M.

  • LaFleur & Godfrey's largest Q1 2018 buy was Thermo Fisher Scientific: 24,715 shares worth $5.1M.
  • LaFleur & Godfrey added most to APA Corp in Q1 2018, an estimated $5.11M increase.
  • LaFleur & Godfrey's biggest Q1 2018 reduction was Apple, cutting an estimated $10.4M.
  • LaFleur & Godfrey fully exited Keurig Dr Pepper in Q1 2018, selling an estimated $5.73M.
  • LaFleur & Godfrey's ten largest holdings make up 42% of its $399M portfolio in Q1 2018.
  • LaFleur & Godfrey opened 3 new positions and closed 15 in Q1 2018.
  • LaFleur & Godfrey's portfolio value fell 2.1% quarter-over-quarter to $399M.

Based on LaFleur & Godfrey's 13F filing for Q1 2018, filed 13 Dec 2018.